Case report: Individualized treatment of advanced breast cancer with the use of the patient-derived tumor-like cell cluster model

被引:2
作者
Xia, Wenjie [1 ]
Chen, Wuzhen [2 ]
Fang, Shan [3 ]
Wu, Jun [1 ]
Zhang, Jingxia [1 ]
Yuan, Hongjun [1 ]
机构
[1] Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Canc Ctr,Gen Surg,Dept Breast Surg, Hangzhou, Peoples R China
[2] Zhejiang Univ, Affiliated Hosp 2, Dept Breast Surg Surg Oncol, Sch Med, Hangzhou, Peoples R China
[3] Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Rehabil & Sports Med Res Inst Zhejiang Prov,Rehabi, Hangzhou, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
breast cancer; individualized treatment; patient-derived tumor model; drug testing; case report; XENOGRAFTS;
D O I
10.3389/fonc.2022.897984
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is one of the most common tumors in women. Despite various treatments, the survival of patients with advanced breast cancer is still disappointing. Furthermore, finding an effective individualized treatment for different kinds of patients is a thorny problem. Patient-derived tumor-like cell clusters were reported to be used for personalized drug testing in cancer therapy and had a prediction accuracy of 93%. However, there is still a lack of case reports about its application in the individualized treatment of breast cancer patients. Here, we described four cases of individualized treatment for advanced breast cancer using the patient-derived tumor-like cell cluster model (PTC model). In these four cases, the PTC model showed a good predictive effect. The tumor size was reduced significantly or even disappeared completely through clinical, radiological, or pathological evaluation with the help of the PTC model for selecting an individualized therapy regimen. Furthermore, the drug sensitivity test results of the PTC model were consistent with pathological molecular typing and the actual clinical drug resistance of the patients. In summary, our case report first evaluated the application value of the PTC model in advanced breast cancer, and the PTC model might be used as an efficient tool for drug resistance screening and for selecting a better personalized treatment, although further study is needed to prove the validity and stability of the PTC model in drug screening.
引用
收藏
页数:8
相关论文
共 16 条
[1]   Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries [J].
Allemani, Claudia ;
Matsuda, Tomohiro ;
Di Carlo, Veronica ;
Harewood, Rhea ;
Matz, Melissa ;
Niksic, Maja ;
Bonaventure, Audrey ;
Valkov, Mikhail ;
Johnson, Christopher J. ;
Esteve, Jacques ;
Ogunbiyi, Olufemi J. ;
Azevedo e Silva, Gulnar ;
Chen, Wan-Qing ;
Eser, Sultan ;
Engholm, Gerda ;
Stiller, Charles A. ;
Monnereau, Alain ;
Woods, Ryan R. ;
Visser, Otto ;
Lim, Gek Hsiang ;
Aitken, Joanne ;
Weir, Hannah K. ;
Coleman, Michel P. .
LANCET, 2018, 391 (10125) :1023-1075
[2]   Interrogating open issues in cancer precision medicine with patient-derived xenografts [J].
Byrne, Annette T. ;
Alferez, Denis G. ;
Amant, Frederic ;
Annibali, Daniela ;
Arribas, Joaquin ;
Biankin, Andrew V. ;
Bruna, Alejandra ;
Budinska, Eva ;
Caldas, Carlos ;
Chang, David K. ;
Clarke, Robert B. ;
Clevers, Hans ;
Coukos, George ;
Dangles-Marie, Virginie ;
Eckhardt, S. Gail ;
Gonzalez-Suarez, Eva ;
Hermans, Els ;
Hidalgo, Manuel ;
Jarzabek, Monika A. ;
de Jong, Steven ;
Jonkers, Jos ;
Kemper, Kristel ;
Lanfrancone, Luisa ;
Maelandsmo, Gunhild Mari ;
Marangoni, Elisabetta ;
Marine, Jean-Christophe ;
Medico, Enzo ;
Norum, Jens Henrik ;
Palmer, Hector G. ;
Peeper, Daniel S. ;
Pelicci, Pier Giuseppe ;
Piris-Gimenez, Alejandro ;
Roman-Roman, Sergio ;
Rueda, Oscar M. ;
Seoane, Joan ;
Serra, Violeta ;
Soucek, Laura ;
Vanhecke, Dominique ;
Villanueva, Alberto ;
Vinolo, Emilie ;
Bertotti, Andrea ;
Trusolino, Livio .
NATURE REVIEWS CANCER, 2017, 17 (04) :254-268
[3]   Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis [J].
Cortazar, Patricia ;
Zhang, Lijun ;
Untch, Michael ;
Mehta, Keyur ;
Costantino, Joseph P. ;
Wolmark, Norman ;
Bonnefoi, Herve ;
Cameron, David ;
Gianni, Luca ;
Valagussa, Pinuccia ;
Swain, Sandra M. ;
Prowell, Tatiana ;
Loibl, Sibylle ;
Wickerham, D. Lawrence ;
Bogaerts, Jan ;
Baselga, Jose ;
Perou, Charles ;
Blumenthal, Gideon ;
Blohmer, Jens ;
Mamounas, Eleftherios P. ;
Bergh, Jonas ;
Semiglazov, Vladimir ;
Justice, Robert ;
Eidtmann, Holger ;
Paik, Soonmyung ;
Piccart, Martine ;
Sridhara, Rajeshwari ;
Fasching, Peter A. ;
Slaets, Leen ;
Tang, Shenghui ;
Gerber, Bernd ;
Geyer, Charles E., Jr. ;
Pazdur, Richard ;
Ditsch, Nina ;
Rastogi, Priya ;
Eiermann, Wolfgang ;
von Minckwitz, Gunter .
LANCET, 2014, 384 (9938) :164-172
[4]   Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics [J].
Ding, Ren-Bo ;
Chen, Ping ;
Rajendran, Barani Kumar ;
Lyu, Xueying ;
Wang, Haitao ;
Bao, Jiaolin ;
Zeng, Jianming ;
Hao, Wenhui ;
Sun, Heng ;
Wong, Ada Hang-Heng ;
Valecha, Monica Vishnu ;
Yang, Eun Ju ;
Su, Sek Man ;
Choi, Tak Kan ;
Liu, Shuiming ;
Chan, Kin Iong ;
Yang, Ling-Lin ;
Wu, Jingbo ;
Miao, Kai ;
Chen, Qiang ;
Shim, Joong Sup ;
Xu, Xiaoling ;
Deng, Chu-Xia .
NATURE COMMUNICATIONS, 2021, 12 (01)
[5]   New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) [J].
Eisenhauer, E. A. ;
Therasse, P. ;
Bogaerts, J. ;
Schwartz, L. H. ;
Sargent, D. ;
Ford, R. ;
Dancey, J. ;
Arbuck, S. ;
Gwyther, S. ;
Mooney, M. ;
Rubinstein, L. ;
Shankar, L. ;
Dodd, L. ;
Kaplan, R. ;
Lacombe, D. ;
Verweij, J. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) :228-247
[6]   High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response [J].
Gao, Hui ;
Korn, Joshua M. ;
Ferretti, Stephane ;
Monahan, John E. ;
Wang, Youzhen ;
Singh, Mallika ;
Zhang, Chao ;
Schnell, Christian ;
Yang, Guizhi ;
Zhang, Yun ;
Balbin, O. Alejandro ;
Barbe, Stephanie ;
Cai, Hongbo ;
Casey, Fergal ;
Chatterjee, Susmita ;
Chiang, Derek Y. ;
Chuai, Shannon ;
Cogan, Shawn M. ;
Collins, Scott D. ;
Dammassa, Ernesta ;
Ebel, Nicolas ;
Embry, Millicent ;
Green, John ;
Kauffmann, Audrey ;
Kowa, Colleen ;
Leary, Rebecca J. ;
Lehar, Joseph ;
Liang, Ying ;
Loo, Alice ;
Lorenzana, Edward ;
McDonald, E. Robert, III ;
McLaughlin, Margaret E. ;
Merkin, Jason ;
Meyer, Ronald ;
Naylor, Tara L. ;
Patawaran, Montesa ;
Reddy, Anupama ;
Roeelli, Claudia ;
Ruddy, David A. ;
Salangsang, Fernando ;
Santacroce, Francesca ;
Singh, Angad P. ;
Tang, Yan ;
Tinetto, Walter ;
Tobler, Sonja ;
Velazquez, Roberto ;
Venkatesan, Kavitha ;
Von Arx, Fabian ;
Wang, Hui Qin ;
Wang, Zongyao .
NATURE MEDICINE, 2015, 21 (11) :1318-1325
[7]  
HARRIS EER, 2018, INT J BREAST CANCER, V2018, DOI DOI 10.1155/2018/4809183
[8]   Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer [J].
Hoadley, Katherine A. ;
Yau, Christina ;
Hinoue, Toshinori ;
Wolf, Denise M. ;
Lazar, Alexander J. ;
Drill, Esther ;
Shen, Ronglai ;
Taylor, Alison M. ;
Cherniack, Andrew D. ;
Thorsson, Vesteinn ;
Akbani, Rehan ;
Bowlby, Reanne ;
Wong, Christopher K. ;
Wiznerowicz, Maciej ;
Sanchez-Vega, Francisco ;
Robertson, A. Gordon ;
Schneider, Barbara G. ;
Lawrence, Michael S. ;
Noushmehr, Houtan ;
Malta, Tathiane M. ;
Stuart, Joshua M. ;
Benz, Christopher C. ;
Laird, Peter W. .
CELL, 2018, 173 (02) :291-+
[9]   An Automated Organoid Platform with Inter-organoid Homogeneity and Inter-patient Heterogeneity [J].
Jiang, Shengwei ;
Zhao, Haoran ;
Zhang, Weijie ;
Wang, Jiaqi ;
Liu, Yuhong ;
Cao, Yuanxiong ;
Zheng, Honghui ;
Hu, Zhiwei ;
Wang, Shubin ;
Zhu, Yu ;
Wang, Wei ;
Cui, Shuzhong ;
Lobie, Peter E. ;
Huang, Laiqiang ;
Ma, Shaohua .
CELL REPORTS MEDICINE, 2020, 1 (09)
[10]   Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy [J].
Kuerer, HM ;
Newman, LA ;
Smith, TL ;
Ames, FC ;
Hunt, KK ;
Dhingra, K ;
Theriault, RL ;
Singh, G ;
Binkley, SM ;
Sneige, N ;
Buchholz, TA ;
Ross, MI ;
McNeese, MD ;
Buzdar, AU ;
Hortobagyi, GN ;
Singletary, SE .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (02) :460-469